Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0463 Transporter Info
Gene Name	SLC7A10
Transporter Name	Asc-type amino acid transporter 1
Gene ID	56301
UniProt ID	Q9NS82

Post-Translational Modification of This DT
Overview of SLC7A10 Modification Sites with Functional and Structural Information
Sequence	M A G H T Q Q P S G R G N P R P A P S P S P V P G T V P G A S E R V A L K K E I G L L S A C T I I I G N I I G S G I F I S P K G V L E H S G S V G L A L F V W V L G G G V T A L G S L C Y A E L G V A I P K S G G D Y A Y V T E I F G G L A G F L L L W S A V L I M Y P T S L A V I S M T F S N Y V L Q P V F P N C I P P T T A S R V L S M A C L M L L T W V N S S S V R W A T R I Q D M F T G G K L L A L S L I I G V G L L Q I F Q G H F E E L R P S N A F A F W M T P S V G H L A L A F L Q G S F A F S G W N F L N Y V T E E M V D A R K N L P R A I F I S I P L V T F V Y T F T N I A Y F T A M S P Q E L L S S N A V A V T F G E K L L G Y F S W V M P V S V A L S T F G G I N G Y L F T Y S R L C F S G A R E G H L P S L L A M I H V R H C T P I P A L L V C C G A T A V I M L V G D T Y T L I N Y V S F I N Y L C Y G V T I L G L L L L R W R R P A L H R P I K V N L L I P V A Y L V F W A F L L V F S F I S E P M V C G V G V I I I L T G V P I F F L G V F W R S K P K C V H R L T E S M T H W G Q E L C F V V Y P Q D A P E E E E N G P C P P S L L P A T D K P S K P Q
PTM type	X-Phosphorylation X-Ufmylation X: Amino Acid

Phosphorylation
Serine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC7A10			[1]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	21
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC7A10 Serine 21 has the potential to affect its expression or activity.
Ufmylation
Unclear Residue	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Promoting cell growth and tumor formation by ER transactivation			[2]
Role of PTM	Influencing the Disease Progression
Related Enzyme	Ufm1-specific protease 2 (UFSP2)
Experimental Material(s)	Human Embryonic Kidney 293T (HEK-293T) cells
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ufmylation at SLC7A10 have been reported to promote cell growth and tumor formation by ER transactivation.

References
1	Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
2	Modification of ASC1 by UFM1 is crucial for ERalpha transactivation and breast cancer development. Mol Cell. 2014 Oct 23;56(2):261-274.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.